Search Results 331-340 of 8030 for 谷歌搜索引擎优化咨询邮箱:lgooxc@hotmail.com
In this study, participants with MSI-H or dMMR advanced colorectal carcinoma will be randomly assigned to receive either pembrolizumab or the Investigator's ...
Occhino, John A. M.D., M.S. · Occhino.John@mayo.edu; Professor of Obstetrics and Gynecology; Publications · Olson, Janet E. Ph.D.
About this study. This study is being done to store blood, buccal (cheek) cells, genetic material including DNA (deoxyribonucleic acid) and RNA (ribonucleic ...
Narrow your search · f · More about research at Mayo Clinic · Mayo Clinic Footer · Mayo Clinic Privacy Policy · Customize Cookie Settings.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Search. Menu. Request appointment · Donate · Diseases ... Search for a disease or condition . Type 3 ... Android App on Google Play · Apple Download on the ...
Search. Menu. Request appointment · Donate ... Mail. Department of Development Mayo Clinic 200 ... Android App on Google Play · Apple Download on the ...
Search. Menu. Request appointment · Donate · Diseases ... Search for a doctor. Bruce Sutor, M.D. ... Android App on Google Play · Apple Download on the ...
This is a phase Ib study of PDR001 in combination with regorafenib in adult patients with previously treated metastatic microsatellite stable (MSS) colorectal ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift to our 2025 Drive to Cure Cancer and transform the way cancer is treated and defeated.